Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salesforce, Inc. Director's Dealing 2024

Nov 23, 2024

29776_dirs_2024-11-22_b8174ac1-0961-4944-8eae-70647f46868f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Salesforce, Inc. (CRM)
CIK: 0001108524
Period of Report: 2024-11-22

Reporting Person: Millham Brian (President and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-22 Common Stock M 2037 $186.51 Acquired 2037 Direct
2024-11-22 Common Stock M 2018 $215.17 Acquired 4055 Direct
2024-11-22 Common Stock M 2107 $218.21 Acquired 6162 Direct
2024-11-22 Common Stock M 8646 $240.95 Acquired 14808 Direct
2024-11-22 Common Stock S 14808 $338.95 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-22 Non-qualified Stock Option (Right to Buy) $186.51 M 2037 Disposed 2030-03-22 Common Stock (2037) Direct
2024-11-22 Non-qualified Stock Option (Right to Buy) $215.17 M 2018 Disposed 2028-03-22 Common Stock (2018) Direct
2024-11-22 Non-qualified Stock Option (Right to Buy) $218.21 M 2107 Disposed 2029-03-22 Common Stock (2107) Direct
2024-11-22 Non-qualified Stock Option (Right to Buy) $240.95 M 8646 Disposed 2028-02-22 Common Stock (8646) Direct

Footnotes

F1: As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.

F2: Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

F3: Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

F4: Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

F5: Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.